What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?

被引：0
|
作者：
Beryl Otieno
Chukwuka Ibecheozor
Marlene S. Williams
机构：
[1] Greater Baltimore Medical Center,Division of Cardiology
[2] The Johns Hopkins University School of Medicine,undefined
[3] The Johns Hopkins University School of Medicine,undefined
来源：
Current Atherosclerosis Reports | 2023年 / 25卷
关键词：
Antiplatelet therapy; Ischemia; Dual antiplatelet therapy; Bleeding; Coronary heart disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：343 / 350
页数：7
相关论文
共 50 条
  • [41] Antiplatelet Therapy in Coronary Disease: What Agent to Use, When, and How?
    Pierre Theroux
    [J]. Journal of Thrombosis and Thrombolysis, 1998, 5 (Suppl 2) : S143 - S150
  • [42] Disease control in patients with relapsed and/or refractory multiple myeloma: what is the optimal duration of therapy?
    Ludwig, Heinz
    Sonneveld, Peter
    [J]. LEUKEMIA RESEARCH, 2012, 36 : S27 - S34
  • [43] Antiplatelet Therapy in Coronary Heart Disease. Some Problems and Achivements
    Gratsiansky, N. A.
    [J]. KARDIOLOGIYA, 2010, 50 (06) : 4 - 21
  • [44] The application of thromboelastogram in detection of indexes of antiplatelet therapy for coronary heart disease
    Zhao, Shu-Wu
    Wang, Yu-Ping
    Xu, Lin-Dong
    Gang, Wei
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 (12) : 3515 - 3520
  • [45] What is the optimal blood pressure and drug therapy for patients with coronary artery disease?
    Pepine, CJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (18): : 2271 - 2273
  • [46] Antiplatelet treatment for coronary heart disease
    Clappers, N.
    Brouwer, M. A.
    Verheugt, F. W. A.
    [J]. HEART, 2007, 93 (02) : 258 - 265
  • [47] Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Bavishi, Chirag
    Trivedi, Vrinda
    Singh, Mandeep
    Katz, Edward
    Messerli, Franz H.
    Bangalore, Sripal
    [J]. AMERICAN JOURNAL OF MEDICINE, 2017, 130 (11): : 1325.e1 - 1325.e12
  • [48] Dual antiplatelet therapy: optimal timing, management, and duration
    Sabouret, Pierre
    Rushton-Smith, Sophie K.
    Kerneis, Mathieu
    Silvain, Johanne
    Collet, Jean-Philippe
    Montalescot, Gilles
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2015, 1 (03) : 198 - 204
  • [49] Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice
    Cho, Min Soo
    Park, Duk-Woo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (05): : 769 - 779
  • [50] Duration of dual antiplatelet therapy in acute coronary syndrome
    Wilson, Simon John
    Newby, David E.
    Dawson, Dana
    Irving, John
    Berry, Colin
    [J]. HEART, 2017, 103 (08) : 573 - 580
12345